April 23, 2024 | Client News
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced that Chief Executive Officer & Chair Punit Dhillon and other members of Skye’s executive team will present […]
April 22, 2024 | Client News
PowerPort Neo is Available for Immediate Orders from Nuvve SAN DIEGO, April 22, 2024 /PRNewswire/ — Nuvve Holding Corp. (the “Company”) (Nasdaq: NVVE), a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform, is pleased to announce the release of upgraded PowerPort Electric Vehicle Supply Equipment (EVSE) models, boasting hardware enhancements and […]
April 22, 2024 | Client News
Nashville, TN, April 22, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (www.americanrebelbeer.com), is proud to announce a distribution agreement with Best Brands Inc (www.bestbrandsinc.com) for the state of […]
April 22, 2024 | Client News
70% of Patients in the Expanded Access Program (EAP) Have Seen Measurable Clinical Improvement in Their Fatigue After Six Months of Follow-up All Patients Have Either Stabilized or Improved on Nasal Foralumab Treatment and No Patients Declined in Key Clinical Measures NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) […]
April 19, 2024 | Client News
– Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) – – Data presented in a platform session at the Annual Meeting of the American Academy of Neurology in Denver, Colorado – NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: […]
April 19, 2024 | Client News
SANTA ANA, Calif., April 18, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer (“NK”) cell therapeutics, today announced that Paul Y. Song, MD, Chairman and Chief Executive Officer of NKGen Biotech, will […]
April 19, 2024 | NASDAQ: LGVN
MIAMI, April 18, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced the closing of its previously announced exercise of certain existing warrants to purchase […]
April 18, 2024 | Client News
American Rebel Holdings Inc Nashville, TN, April 18, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (www.americanrebelbeer.com), is proud to announce a distribution agreement with Standard Beverage Corporation […]
April 18, 2024 | Client News, NASDAQ: LASE
ORLANDO, Fla., April 18, 2024–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for cleaning and other material processing applications, announced today that it is attending the 2024 Government Fleet Expo & Conference (GFX), the largest annual conference for public fleets in the nation. Set to take place from May 7 to […]
